Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Myriad Genetics Inc.
DescriptionMolecular diagnostic consisting of a panel of 46 genes involved in cell cycle progression (CCP)
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetermine treatment regimens for prostate cancer patients; Predict PSA biochemical recurrence in patients following radiation therapy; Predict risk of death from prostate cancer; Predict the risk of cancer recurrence following radical prostatectomy
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today